Can Tirzepatide Cause Hair Loss — and What Should You Do About It?

Is tirzepatide to blame, or is it the weight loss?

The honest answer is: probably the weight loss. Tirzepatide does not appear in the Mounjaro SmPC as a cause of hair loss, and the NHS medicines page for tirzepatide does not list it among the recognised side effects. What does cause hair shedding in this context is the physical stress of losing weight quickly, and tirzepatide, which produced average losses of around 20% of body weight over 72 weeks in clinical trials, delivers significant and rapid change to the body.

Telogen effluvium is the mechanism. Under nutritional or physiological stress, a larger proportion of hair follicles shift from the growth phase into the resting phase simultaneously. Around two to four months later, those resting hairs shed together. The timing (typically after the first few months of treatment) is exactly what many people on tirzepatide describe, and if you want a dedicated look at why tirzepatide is associated with hair loss and what the evidence shows, that is covered in more detail. It can feel alarming, but it is a biological response to change rather than a signal that something is going wrong.

If you want to explore the broader pattern of hair changes reported by people taking Mounjaro, there is more detail on that question. The short version: the evidence does not point to tirzepatide itself as the agent.

The nutritional factors that can make it worse

Even if tirzepatide is not the direct cause, what you eat during treatment matters. Appetite suppression is strong, particularly in the early months. If overall intake drops sharply without attention to protein, iron, ferritin and zinc, the follicle-level stress compounds. Protein is the most important: hair is almost entirely keratin, and a consistent shortfall (easy to accumulate when you are eating significantly less) accelerates the shed.

This is not a reason to avoid treatment; it is a reason to pay attention to food quality rather than just quantity. Prioritising protein-rich foods at every meal, staying well hydrated, and speaking to your prescriber if your appetite is dramatically suppressed are all practical steps. The question of how to reduce hair loss while on tirzepatide covers the dietary and lifestyle side of this in more detail.

Blood tests are useful here. Low ferritin, in particular, is a common but under-detected contributor to diffuse hair shedding and is treatable. Your GP can check this alongside a routine review.

When should hair loss prompt medical attention?

Most shedding in this context is diffuse (spread evenly across the scalp) and self-limiting. It usually slows as weight stabilises and nutrition catches up. That is the pattern to expect, and our prescribers see it discussed regularly.

There are situations, however, that call for a prompt conversation with your GP or prescriber. Seek advice if the loss is patchy or asymmetric, if you notice bald patches rather than general thinning, if it begins very suddenly, or if it is accompanied by fatigue, cold intolerance, brittle nails or other systemic signs that might point to thyroid dysfunction or another underlying cause. Tirzepatide can occasionally unmask conditions that were already present.

It is also worth knowing that anxiety and mood changes are occasionally reported during treatment. If those accompany the hair changes, the page on tirzepatide and anxiety may be relevant, and both topics are worth raising with your prescriber at the same time.

For a broader picture of the documented side-effect profile, the Mounjaro side effects page covers the full range from the most common GI effects through to rarer signals, including guidance on whether tirzepatide can cause diarrhea and how to manage it. The NHS medicines information for tirzepatide also lists the recognised side effects as reported in clinical trials, a reliable first reference if you want to check what has been formally recorded.

Reporting side effects and what to do next

If you experience hair loss during tirzepatide treatment that concerns you, you can report it as a suspected side effect through the MHRA's Yellow Card scheme at yellowcard.mhra.gov.uk. Reporting helps build the post-market safety picture for newer medicines, and tirzepatide carries a Black Triangle (▼) designation indicating it is under additional surveillance.

At the same time, log the timing: when did shedding start relative to your first dose or a dose increase? Is it getting better or worse? That detail is genuinely useful for your prescriber. Hair loss alone is rarely a clinical reason to stop treatment, but you deserve an informed, personalised view rather than a general reassurance.

At nume, a real prescriber (not an automated system) reviews your consultation and remains available for aftercare. If a side effect like this comes up after you start, our prescribers can advise. You can explore what is included when you start your free consultation.